Company profile: Marken
1.1 - Company Overview
Company description
- Provider of patient-centric clinical trial logistics for the pharmaceutical and life sciences industries, including clinical trial sample delivery, chain of custody shipping, global control center monitoring, real-time clinical shipment tracking, vaccine trial storage, and a home healthcare management system; maintains a leading position in Direct to Patient services and biological sample shipments.
Products and services
- Global Control Center: Orchestrates worldwide logistics operations through centralized monitoring and management to ensure timely, accurate delivery of clinical trial materials, enterprise-grade centralized control
- Chain of Custody Shipping: Secures and documents transfers of clinical trial materials to maintain integrity and compliance during transport, industrial-grade chain-of-custody tracking ensuring documented integrity
- Clinical Trial Sample Delivery: Delivers clinical trial samples from collection points to laboratories or storage facilities with accurate routing and timing, clinical-grade transport for biological sample shipments
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Marken
Trials.ai
HQ: United States
Website
- Description: Provider of an AI-powered Smart Protocol system that optimizes clinical trial protocols and guides research teams in designing trials for speed and success, helping pharma, biotech, and device companies get treatments to patients faster.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Trials.ai company profile →
Maaguzi
HQ: United States
Website
- Description: Provider of web-based and mobile Patient Reported Outcomes (PRO) and Site Reported Data Collection solutions for the life science industry, delivered via OutcomeLogix and used in therapeutic areas including Men's Health, Endocrinology, Respiratory, and CNS areas such as Depression, Anxiety, and Schizophrenia.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Maaguzi company profile →
Saliency
HQ: United States
Website
- Description: Provider of medical imaging workflow automation for clinical trials, halving turnaround time for quality control, preparation of images for physician review, and image annotations. Solutions customized for imaging modality and therapeutic area.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Saliency company profile →
Tx3
HQ: United States
Website
- Description: Provider of automated quality and compliance SaaS solutions for software testing within Life Science companies, enabling agile adoption and efficient adherence to regulatory requirements such as 21 CFR Part 11. Offerings include Tricentis Tosca, qTest, NeoLoad, LiveCompare, and Data Integrity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tx3 company profile →
CoreBiome
HQ: United States
Website
- Description: Provider of fast, accurate genomic profiles of microbial communities (microbiomes) for pharmaceutical, agriculture, and academic research customers, using proprietary reagents and informatics to enable rapid, affordable, and highly accurate measurement and interpretation of microbial diversity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CoreBiome company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Marken
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Marken
2.2 - Growth funds investing in similar companies to Marken
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Marken
4.2 - Public trading comparable groups for Marken
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →